|
Dear Edson Neto, |
Based on the papers you've read, we think you might be interested in this recently published article from Academia Oncology: Targeting DNA repair in lung cancer with PARP inhibitors
|
| Lung cancer is a global burden affecting millions of individuals worldwide. Projections indicate a substantial rise in incidence by 2045, with an estimated increase of 131% in males and 105% in females, respectively. Although many therapies are approved for treating lung cancers, the development of acquired... Read more |
|
|
|---|
|
|
Academia Oncology is an innovative open access journal publishing original research and review articles covering all areas of oncology. The editors welcome interdisciplinary submissions from the cutting edge of oncology research, in particular, those that drive connectivity between disciplines. |
|
|
|---|
|
|
|
|
Graham P. Pidgeon
Read later